| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.965.688 | 3.341.560 | 3.858.919 | 4.392.510 | 4.612.381 | 6.124.259 | 5.587.380 | 4.702.809 | 6.371.859 | 7.353.460 |
| Total Income - EUR | 3.036.815 | 3.430.527 | 3.890.691 | 4.427.270 | 4.645.238 | 6.150.357 | 5.595.567 | 4.752.639 | 6.423.803 | 7.387.837 |
| Total Expenses - EUR | 2.645.974 | 2.912.838 | 3.403.530 | 3.830.097 | 4.032.709 | 5.341.915 | 5.227.317 | 4.487.457 | 6.080.767 | 7.013.481 |
| Gross Profit/Loss - EUR | 390.840 | 517.689 | 487.161 | 597.173 | 612.529 | 808.442 | 368.250 | 265.182 | 343.036 | 374.356 |
| Net Profit/Loss - EUR | 335.433 | 448.684 | 420.740 | 517.220 | 529.340 | 702.734 | 320.485 | 219.844 | 286.746 | 301.149 |
| Employees | 5 | 5 | 6 | 6 | 0 | 7 | 7 | 7 | 6 | 6 |
Check the financial reports for the company - Dopharma Vet S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 837.856 | 844.534 | 835.359 | 788.857 | 788.624 | 781.912 | 742.182 | 717.777 | 718.688 | 766.254 |
| Current Assets | 1.815.377 | 1.703.610 | 1.981.848 | 2.309.412 | 2.874.663 | 3.135.235 | 3.176.624 | 2.866.484 | 3.299.670 | 3.362.535 |
| Inventories | 943.687 | 660.261 | 934.969 | 1.139.363 | 1.596.896 | 1.565.707 | 1.535.036 | 1.195.090 | 1.709.030 | 1.669.356 |
| Receivables | 678.552 | 819.282 | 855.747 | 1.003.186 | 1.071.077 | 1.352.947 | 1.385.971 | 1.495.292 | 1.438.573 | 1.539.450 |
| Cash | 193.138 | 224.067 | 191.132 | 166.863 | 206.690 | 216.581 | 255.617 | 176.102 | 152.067 | 153.728 |
| Shareholders Funds | 1.018.106 | 642.268 | 1.052.139 | 1.550.050 | 2.049.372 | 2.713.254 | 2.312.907 | 2.539.927 | 2.591.343 | 2.878.009 |
| Social Capital | 7.829 | 7.749 | 7.618 | 7.478 | 7.333 | 7.194 | 7.035 | 7.057 | 7.035 | 6.996 |
| Debts | 1.636.564 | 1.907.095 | 1.765.982 | 1.549.309 | 1.616.458 | 1.205.842 | 1.608.674 | 1.047.464 | 1.430.152 | 1.251.462 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Dopharma Vet S.r.l.